| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |







From the Departments of Pathology *
and
Neurosurgery,¶
National Cardiovascular Center,
Suita City, Japan; Licensing Business
Development,
R&D Operations, Dainippon
Pharmaceutical Co. Ltd., Suita City, Japan; the Department of
Neuroanatomy,
Kanazawa University School of
Medicine, Kanazawa City, Japan; the Department of
Pathology,||
Osaka Rosai Hospital, Sakai City, Japan; the
Department of Pathology,
Osaka University
Graduate School of Medicine, Suita City, Japan; and the Department of
Physiology and Cellular Biophysics,**
College of
Physicians and Surgeons, Columbia University, New York, New York
RA301/Tra2ß, a sequence-specific RNA-binding protein, was first cloned as a stress molecule in re-oxygenated astrocytes. In human vascular tissues, we have found enhanced RA301/Tra2ß expression in coronary artery with intimal thickening, and atherosclerotic aorta. Balloon injury to the rat carotid artery induced RA301/Tra2ß transcripts followed by expression of the antigen, which was detected in medial and neointimal vascular smooth muscle cells (VSMCs). In cultured VSMCs, hypoxia/re-oxygenation caused induction of RA301/Tra2ß and was accompanied by cell proliferation, both of which were blocked by the addition of either diphenyl iodonium, a NADPH oxidase inhibitor, PD98059, a mitogen-activated protein kinase kinase inhibitor, or antisense oligonucleotide for RA301/Tra2ß. Consistent with a link between RA301/Tra2ß and cell proliferation, platelet-derived growth factor also induced expression of RA301/Tra2ß in cultured VSMCs. These data suggest a possible role for RA301/Tra2ß in the regulation of VSMC proliferation, especially in the setting of hypoxia/re-oxygenation-induced cell stress.
This article has been cited by other articles:
![]() |
T. Novoyatleva, B. Heinrich, Y. Tang, N. Benderska, M. E.R. Butchbach, C. L. Lorson, M. A. Lorson, C. Ben-Dov, P. Fehlbaum, L. Bracco, et al. Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing Hum. Mol. Genet., January 1, 2008; 17(1): 52 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Watermann, Y. Tang, A. zur Hausen, M. Jager, S. Stamm, and E. Stickeler Splicing Factor Tra2-{beta}1 Is Specifically Induced in Breast Cancer and Regulates Alternative Splicing of the CD44 Gene. Cancer Res., May 1, 2006; 66(9): 4774 - 4780. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Venables, C. F. Bourgeois, C. Dalgliesh, L. Kister, J. Stevenin, and D. J. Elliott Up-regulation of the ubiquitous alternative splicing factor Tra2{beta} causes inclusion of a germ cell-specific exon Hum. Mol. Genet., August 15, 2005; 14(16): 2289 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Forrest, K. G. Barringhaus, D. Perlegas, M.-L. Hammarskjold, and C. A. McNamara Intron Retention Generates a Novel Id3 Isoform That Inhibits Vascular Lesion Formation J. Biol. Chem., July 30, 2004; 279(31): 32897 - 32903. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stoilov, R. Daoud, O. Nayler, and S. Stamm Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA Hum. Mol. Genet., March 1, 2004; 13(5): 509 - 524. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |